BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Compound Therapeutics 

100 Beaver Street

Waltham  Massachusetts  02453  U.S.A.
Phone: 781-891-3745 Fax: 781-891-3796


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Compound Therapeutics Becomes Adnexus Therapeutics 6/22/2006 2:44:02 PM    More...
BioSpace Celebrates A Decade Of Genetown™ 10/19/2005 5:12:28 PM    More...
Compound Therapeutics Raises $15.5 Million To Advance Product Pipeline Into Clinic 10/19/2005 5:12:20 PM    More...
Compound Therapeutics Appoints Katrine Bosley As VP Of Business Development 10/19/2005 5:11:29 PM    More...
Compound Therapeutics And Abbott Laboratories (ABT) Enter Into Technology License Agreement For Drug Discovery 10/19/2005 5:11:23 PM    More...
Compound Therapeutics Strengthens Company Leadership With Addition Of Prominent Life Science Professionals 10/19/2005 5:10:43 PM    More...
Compound Therapeutics Appoints John Edwards As VP Of Commercial Development 10/19/2005 5:10:21 PM    More...
Compound Therapeutics Announces Acquisition Of Strategic Assets Of Phylos, Inc. 10/19/2005 5:10:21 PM    More...
Compound Therapeutics Announces Initiation Of IND-enabling Safety Studies With Lead Oncology Product; First Of A New Class Of Protein Therapeutics 10/19/2005 5:09:19 PM    More...
Compound Therapeutics Appoints Dr. John Mendlein As CEO; Biotech Executive To Accelerate Partnering And Development Of A Breakthrough Class Of Pharmaceuticals 10/19/2005 5:08:55 PM    More...

//-->